Prospective Analysis of urINe LAM to Eliminate NTM Sputum Screening (PAINLESS) study: Rationale and trial design for testing urine lipoarabinomannan as a marker of NTM lung infection in cystic fibrosis.

<h4>Background</h4>Routine screening for nontuberculous mycobacterial (NTM) lung disease is dependent on sputum cultures. This is particularly challenging in the cystic fibrosis (CF) population due to reduced sputum production and low culture sensitivity. Biomarkers of infection that do not rely on...

Celý popis

Uloženo v:

Podrobná bibliografie
Hlavní autoři:	Kara M Calhoun, Emily Armantrout, Katie Poch, Silvia Caceres, Valerie K Lovell, Marion Jones, Kenneth C Malcolm, Brian Vestal, Emily Wheeler, Noel Rysavy, Jordan Manzer, Ibrahim Aboellail, Delphi Chatterjee, Jerry A Nick
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Public Library of Science (PLoS) 2025-01-01
Edice:	PLoS ONE
On-line přístup:	https://doi.org/10.1371/journal.pone.0309191
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Prospective Analysis of urINe LAM to Eliminate NTM Sputum Screening (PAINLESS) study: Rationale and trial design for testing urine lipoarabinomannan as a marker of NTM lung infection in cystic fibrosis.

Podobné jednotky